DDIT3 and diffuse large B-cell lymphoma: Interestingly, preclinical data on DLBCL cell lines suggest that dependency on anti-apoptotic proteins, assessed by BH3 profiling, is altered following exposure to CHOP or CHOP compounds underlining the potential of BH3 profiling in predicting therapy outcomes [113].